NEW YORK--(BUSINESS WIRE)--Enzo Biochem Inc. (NYSE:ENZ) today reported results for the fiscal second quarter ended January 31, 2015.
•Year over year revenues for the quarter and first half both increased, despite persisting unusually adverse winter conditions which adversely affected the Clinical Lab. •Clinical Lab revenue increased 6% for the second quarter compared to the year earlier period.
Help employers find you! Check out all the jobs and post your resume.
